(Q54625550)
Statements
Trastuzumab-DM1: building a chemotherapy-free road in the treatment of human epidermal growth factor receptor 2-positive breast cancer. (English)
Jose Baselga
1 reference
Steven J Isakoff
20 December 2010
29
4
351-354